NO20024590L - Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation - Google Patents

Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation

Info

Publication number: NO20024590L
Authority: NO; Norway
Prior art keywords: oligosaccharides; preparation; pharmaceutical preparations; new; preparations containing
Prior art date: 2000-03-28

Application number

NO20024590A

Other languages

Norwegian (no)

Other versions

NO20024590D0 (en

Inventor

Pierre Mourier

Elisabeth Perrin

Christian Viskov

Original Assignee

Aventis Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-28

Filing date

2002-09-25

Publication date

2002-09-25

2002-09-25 Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa

2002-09-25 Publication of NO20024590D0 publication Critical patent/NO20024590D0/en

2002-09-25 Publication of NO20024590L publication Critical patent/NO20024590L/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
- C08B37/0078—Degradation products

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Physical Education & Sports Medicine (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Biotechnology (AREA)
Orthopedic Medicine & Surgery (AREA)
Genetics & Genomics (AREA)
Heart & Thoracic Surgery (AREA)
Crystallography & Structural Chemistry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Communicable Diseases (AREA)
Pain & Pain Management (AREA)
Materials Engineering (AREA)
Polymers & Plastics (AREA)
Oncology (AREA)
Immunology (AREA)
Dermatology (AREA)
Epidemiology (AREA)

NO20024590A 2000-03-28 2002-09-25 Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation NO20024590L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0003910A FR2807043B1 (en)	2000-03-28	2000-03-28	PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION
PCT/FR2001/000903 WO2001072762A1 (en)	2000-03-28	2001-03-26	Pharmaceutical compositions containing oligosaccharides and preparation thereof

Publications (2)

Publication Number	Publication Date
NO20024590D0 NO20024590D0 (en)	2002-09-25
NO20024590L true NO20024590L (en)	2002-09-25

Family

ID=8848572

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024590A NO20024590L (en)	2000-03-28	2002-09-25	Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation

Country Status (26)

Country	Link
EP (1)	EP1272499B1 (en)
JP (1)	JP2003529570A (en)
KR (1)	KR20030001394A (en)
CN (1)	CN1183149C (en)
AR (1)	AR034251A1 (en)
AT (1)	ATE290543T1 (en)
AU (1)	AU782713B2 (en)
BR (1)	BR0109617A (en)
CA (1)	CA2403906A1 (en)
DE (1)	DE60109279T2 (en)
EA (1)	EA004768B1 (en)
EE (1)	EE200200551A (en)
ES (1)	ES2236206T3 (en)
FR (1)	FR2807043B1 (en)
HU (1)	HUP0300330A3 (en)
IL (1)	IL151832A0 (en)
ME (1)	MEP88408A (en)
MX (1)	MXPA02009455A (en)
NO (1)	NO20024590L (en)
NZ (1)	NZ521558A (en)
PL (1)	PL204419B1 (en)
PT (1)	PT1272499E (en)
SK (1)	SK286745B6 (en)
WO (1)	WO2001072762A1 (en)
YU (1)	YU72802A (en)
ZA (1)	ZA200207707B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6750207B1 (en) *	1992-05-01	2004-06-15	Yeda Research And Development Co. Ltd.	Compositions for the regulation of cytokine activity
FR2845686B1 (en) *	2002-10-10	2013-08-30	Aventis Pharma Sa	MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7511026B2 (en) *	2003-03-25	2009-03-31	Seikagaku Corporation	Therapeutic agent for nerve damage
FR2857971B1 (en) *	2003-07-24	2005-08-26	Aventis Pharma Sa	MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20050186679A1 (en) *	2004-02-24	2005-08-25	Christian Viskov	Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (en)	2005-07-20	2013-01-09	帝國製薬株式会社	Use of anti-neuropathic pain effects of D-allose and D-psicose
WO2007026485A1 (en)	2005-08-30	2007-03-08	Inter-University Research Institute Corporation National Institutes Of Natural Sciences	Universal base
EP3418287A1 (en) *	2017-06-21	2018-12-26	Universität für Bodenkultur Wien	Chemical release of asparaginelinked glycans
CN115317507A (en) *	2022-09-19	2022-11-11	中国科学院海洋研究所	Application of Low Molecular Weight Fucoidan Sulfate in the Preparation of Anti-ADHD Drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5449688A (en) *	1993-03-30	1995-09-12	The United States Of America As Represented By The Department Of Health And Human Services	Method of treating chronic inflammatory diseases

2000
- 2000-03-28 FR FR0003910A patent/FR2807043B1/en not_active Expired - Fee Related
2001
- 2001-03-26 KR KR1020027012867A patent/KR20030001394A/en not_active Ceased
- 2001-03-26 BR BR0109617-6A patent/BR0109617A/en not_active IP Right Cessation
- 2001-03-26 MX MXPA02009455A patent/MXPA02009455A/en active IP Right Grant
- 2001-03-26 PL PL357301A patent/PL204419B1/en unknown
- 2001-03-26 EA EA200201024A patent/EA004768B1/en not_active IP Right Cessation
- 2001-03-26 WO PCT/FR2001/000903 patent/WO2001072762A1/en not_active Ceased
- 2001-03-26 EP EP01919561A patent/EP1272499B1/en not_active Expired - Lifetime
- 2001-03-26 CN CNB018084087A patent/CN1183149C/en not_active Expired - Fee Related
- 2001-03-26 JP JP2001570671A patent/JP2003529570A/en active Pending
- 2001-03-26 SK SK1393-2002A patent/SK286745B6/en not_active IP Right Cessation
- 2001-03-26 HU HU0300330A patent/HUP0300330A3/en unknown
- 2001-03-26 PT PT01919561T patent/PT1272499E/en unknown
- 2001-03-26 YU YU72802A patent/YU72802A/en unknown
- 2001-03-26 ES ES01919561T patent/ES2236206T3/en not_active Expired - Lifetime
- 2001-03-26 ME MEP-884/08A patent/MEP88408A/en unknown
- 2001-03-26 CA CA002403906A patent/CA2403906A1/en not_active Abandoned
- 2001-03-26 EE EEP200200551A patent/EE200200551A/en unknown
- 2001-03-26 AT AT01919561T patent/ATE290543T1/en not_active IP Right Cessation
- 2001-03-26 IL IL15183201A patent/IL151832A0/en unknown
- 2001-03-26 NZ NZ521558A patent/NZ521558A/en not_active IP Right Cessation
- 2001-03-26 DE DE60109279T patent/DE60109279T2/en not_active Expired - Fee Related
- 2001-03-26 AU AU46639/01A patent/AU782713B2/en not_active Ceased
- 2001-03-27 AR ARP010101456A patent/AR034251A1/en unknown
2002
- 2002-09-25 ZA ZA200207707A patent/ZA200207707B/en unknown
- 2002-09-25 NO NO20024590A patent/NO20024590L/en unknown

Also Published As

Publication number	Publication date
SK13932002A3 (en)	2003-06-03
MEP88408A (en)	2011-12-20
JP2003529570A (en)	2003-10-07
ATE290543T1 (en)	2005-03-15
FR2807043B1 (en)	2002-11-22
EA004768B1 (en)	2004-08-26
DE60109279D1 (en)	2005-04-14
CN1426419A (en)	2003-06-25
NZ521558A (en)	2005-10-28
HUP0300330A3 (en)	2003-09-29
ES2236206T3 (en)	2005-07-16
NO20024590D0 (en)	2002-09-25
CA2403906A1 (en)	2001-10-04
PT1272499E (en)	2005-06-30
IL151832A0 (en)	2003-04-10
BR0109617A (en)	2003-02-04
EE200200551A (en)	2004-04-15
AR034251A1 (en)	2004-02-18
MXPA02009455A (en)	2003-02-12
WO2001072762A1 (en)	2001-10-04
EA200201024A1 (en)	2003-02-27
HUP0300330A2 (en)	2003-06-28
EP1272499B1 (en)	2005-03-09
EP1272499A1 (en)	2003-01-08
ZA200207707B (en)	2003-12-24
PL204419B1 (en)	2010-01-29
AU4663901A (en)	2001-10-08
FR2807043A1 (en)	2001-10-05
CN1183149C (en)	2005-01-05
PL357301A1 (en)	2004-07-26
DE60109279T2 (en)	2006-04-13
YU72802A (en)	2006-01-16
KR20030001394A (en)	2003-01-06
SK286745B6 (en)	2009-04-06
AU782713B2 (en)	2005-08-25
HK1056564A1 (en)	2004-02-20

Publication	Publication Date	Title
NO20032187D0 (en)	2003-05-14	Heterocyclylalkylpiperidine derivatives, their preparation and preparations containing the compounds
NO982580L (en)	1998-06-05	New taxoids, their preparation and pharmaceutical preparations containing the taxoids
NO20024176L (en)	2002-10-29	Pharmaceutical preparations contain derivatives of 3-amino-azetidine, the new derivatives and their preparation
NO20024175D0 (en)	2002-09-02	Acetidine derivatives, their preparation and pharmaceutical compounds containing the same
NO20010013D0 (en)	2001-01-02	Sulfur-substituted sulfonylaminocarboxylic acid N-arylamides, their preparation and use as well as pharmaceutical preparations containing the compounds
NO20032438D0 (en)	2003-05-28	Ortho and Metasubstituted Bis-Aryl Compounds, Their Preparation and Use, and Pharmaceutical Preparations Containing the Compounds
NO20030296L (en)	2003-01-20	Heparin-derived polysaccharide mixtures, their preparation and pharmaceutical compositions containing the compositions
NO973923D0 (en)	1997-08-26	New taxoids, their preparation as well as pharmaceutical preparations containing the compounds
NO20023400L (en)	2002-09-09	New compounds with hypolidemic and hypocholesterolemic effect, their preparation and preparations containing the compounds
NO992102D0 (en)	1999-04-30	Peptide composition, as well as pharmaceutical composition and cancer vaccine including the peptide composition
NO20005146D0 (en)	2000-10-13	Thienylazolylalkoxyethanamines, their preparation and their use as drugs
DK1098874T3 (en)	2003-10-06	Benzocycloheptenes, Methods of Preparation, Pharmaceutical Preparations Containing Them, and Their Use in the Preparation of Drugs
NO20016247L (en)	2002-02-08	Streptogramin derivatives, their preparation and preparations containing the derivatives
NO995745D0 (en)	1999-11-23	New Derivatives of Erythromycin, Methods of Preparation thereof, and Their Use as Medicines
NO20003661L (en)	2000-09-19	New pentasaccharides, methods for their preparation and pharmaceutical preparations containing the same
NO20041773L (en)	2004-06-29	Pharmaceutical preparations for reducing cell activity and their use.
PT1228039E (en)	2004-09-30	N-GUANIDINOALQUILAMIDES ITS PREPARATION ITS USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME
NO983472D0 (en)	1998-07-28	Taxoids, their preparation and pharmaceutical preparations containing the taxoids
NO20024590D0 (en)	2002-09-25	Pharmaceutical preparations containing oligosaccharides, the new oligosaccharides and their preparation
DK1118610T3 (en)	2002-12-16	Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing the derivatives
NO20035163D0 (en)	2003-11-20	New piperidinecarboxamide derivatives, processes for their preparation and pharmaceutical preparations containing the same
DK199900435U3 (en)	2000-02-11	Pharmaceutical preparation comprising paroxetine methanesulfonate and use thereof
NO985171D0 (en)	1998-11-05	Sulfonamide-substituted fused 5-ring compounds, their use as a medicament, and pharmaceutical preparations containing the compounds
NO20025028D0 (en)	2002-10-18	9-Oxa Epotilone Derivatives, Processes for their Preparation and Their Use in Pharmaceutical Preparations
NO20014692D0 (en)	2001-09-27	3-amidinobenzenesulfonamide derivatives, medical compositions containing them and intermediates in the preparation thereof